Commonwealth Equity Services
MBRX icon

Commonwealth Equity Services’s Moleculin Biotech MBRX Stock Holding History

Commonwealth Equity Services’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Hold
0
– -$10K – 2905
2019
Q4 		– Hold
0
– – – 2871
2019
Q3 		– Hold
0
– – – 2814
2019
Q2 		– Hold
0
– – – 2757
2019
Q1 		– Hold
0
– – – 2714
2018
Q4 		– Hold
0
– – – 2649
2018
Q3 		– Hold
0
– – – 2719
2018
Q2 		– Hold
0
– – – 2678
2018
Q1 		– Hold
0
– – – 2631
2017
Q4 		– Hold
0
– – – 2596
2017
Q3 		– Hold
0
– – – 2495

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Whitegate Investment Counselors
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Raymond James Financial Services Advisors
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return